Hypophosphatemia clinical trials

Explore recruiting hypophosphatemia clinical trials.

Recruiting hypophosphatemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypophosphatemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients with X-linked Hypophosphatemia

Germany, Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Improved Recovery by Iron following Surgery with blood loss, a double-blind multi-centre randomized controlled phase III drug trial (the IRIS-trial)

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

POMREP - Efficacy and safety of zoledronate versus placebo on pain at week 12 in pediatric patients with chronic recurrent multifocal osteomyelitis resistant to non-steroidal anti-inflammatory drug

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Hypophosphatemia trials by city

Hypophosphatemia in Toronto Hypophosphatemia in Vancouver Hypophosphatemia in Montreal Hypophosphatemia in Calgary Hypophosphatemia in Edmonton Hypophosphatemia in Ottawa Hypophosphatemia in Winnipeg Hypophosphatemia in Quebec City Hypophosphatemia in Hamilton Hypophosphatemia in Kitchener Hypophosphatemia in London Hypophosphatemia in Halifax Hypophosphatemia in New York Hypophosphatemia in Los Angeles Hypophosphatemia in Chicago Hypophosphatemia in Houston

Hypophosphatemia clinical trials

Recruiting hypophosphatemia studies right now

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

Phosphate in Acute Pancreatitis

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

The Impact of Phosphate Metabolism on Healthy Aging

Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.

IV Iron-induced Hypophosphatemia After RYGB

Also recruiting in Europe

A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients with X-linked Hypophosphatemia

Improved Recovery by Iron following Surgery with blood loss, a double-blind multi-centre randomized controlled phase III drug trial (the IRIS-trial)

POMREP - Efficacy and safety of zoledronate versus placebo on pain at week 12 in pediatric patients with chronic recurrent multifocal osteomyelitis resistant to non-steroidal anti-inflammatory drug

Hypophosphatemia trials by city

Other conditions